Skip to main content
. 2016 Jul 29;7(37):59820–59833. doi: 10.18632/oncotarget.10930

Table 1. Relative survival rates of hepatocellular carcinoma patients during the periods of 1983-1992, 1993-2002, and 2003-2012 at eighteen SEER sites.

Age Group Decade
1983-1992 1993-2002 2003-2012
6-Mo RSR
 All 31.0 ± 0.7 (4333) 42.9 ± 0.4(15805)*** 57.2 ± 0.2(43502)***
 0-39 46.8 ± 3.4(211) 51.2 ± 2.3 (505)*** 62.0 ± 1.7(811)***
 40-54 32.6 ± 1.8(674) 45.3 ± 0.8(3801)*** 58.5 ± 0.5(10031)***
 55-69 31.3 ± 1.1(1825) 45.7 ± 0.7(5890)*** 60.1 ± 0.3(20763)***
 70+ 27.9 ± 1.1(1623) 37.5 ± 0.7(5599)*** 50.6 ± 0.5(11897)***
12-Mo RSR
 All 18.0 ± 0.6 29.7 ± 0.4*** 44.5 ± 0.3***
 0-39 35.3 ± 3.3 40.1 ± 2.2 52.3 ± 1.8***
 40-54 21.1 ± 1.6 32.8 ± 0.8*** 45.8 ± 0.5***
 55-69 17.5 ± 0.9 31.6 ± 0.6*** 47.5 ± 0.4***
 70+ 15.1 ± 0.9 24.6 ± 0.6*** 37.7 ± 0.5***
24-Mo RSR
 All 10.3± 0.5 19.4 ± 0.3*** 31.4 ± 0.2***
 0-39 24.4 ± 3.0 29.0 ± 2.1 40.0 ± 1.8***
 40-54 11.8 ± 1.3 22.3 ± 0.7*** 33.0 ± 0.5***
 55-69 9.6 ± 0.7 21.0 ± 0.5*** 34.1 ± 0.4***
 70+ 8.6 ± 0.7 14.7 ± 0.5*** 24.7 ± 0.5***
36-Mo RSR
 All 7.3 ± 0.4 14.7 ± 0.3*** 24.8 ± 0.2***
 0-39 18.0 ± 2.7 23.8 ± 1.9 33.7 ± 1.8**
 40-54 7.9 ± 1.1 18.3 ± 0.6*** 27.2 ± 0.5***
 55-69 6.7 ± 0.6 15.9 ± 0.5*** 27.0 ± 0.4***
 70+ 6.3 ± 0.7 9.8 ± 0.4*** 18.0 ± 0.4***
60-Mo RSR
 All 4.7 ± 0.4 10.6 ± 0.3*** 18.2 ± 0.2***
 0-39 13.5 ± 2.4 18.9 ± 1.8 28.8 ± 1.9**
 40-54 5.6 ± 0.9 14.9 ± 0.6*** 21.2 ± 0.5***
 55-69 3.7 ± 0.5 11.1 ± 0.4*** 20.1 ± 0.4***
 70+ 4.3 ± 0.6 5.9 ± 0.4 11.1 ± 0.4***

Abbreviations: Mo, month; RSR, relative survival rate; SEM, standard error of the mean.

*

p < 0.01,

**

p < 0.001, and

***

p < 0.0001 for comparisons with the preceding decade.